abnormal enterocyte proliferation, abnormal eye muscle morphology, abnormal hepatocyte physiology, abnormal inferior vena cava topology, abnormal intestinal enteroendocrine cell morphology, abnormal intestinal epithelium morphology, abnormal intestinal goblet cell morphology, abnormal intestine development, abnormal lean body mass, abnormal Mullerian duct morphology, abnormal nasal septum morphology, abnormal neurohypophysis morphology, abnormal pituitary intermediate lobe morphology, abnormal pulmonary valve cusp morphology, abnormal response/metabolism to endogenous compounds, abnormal small intestine goblet cell morphology, abnormal umbilical vein topology, abnormal ureter topology, abnormal vertebral artery topology, abnormal Wolffian duct morphology, absent ductus venosus valve, absent gastric milk in neonates, absent Paneth cells, basisphenoid bone foramen, cellular phenotype, common truncal valve, decreased birth body size, decreased birth weight, decreased body size, decreased circulating alkaline phosphatase level, decreased circulating glucose level, decreased enterocyte cell number, decreased food intake, decreased insulin secretion, decreased lean body mass, decreased locomotor activity, decreased pancreatic beta cell mass, decreased Paneth cell number, dilated liver sinusoidal spaces, duplication of ductus venosus, ectopic Paneth cells, embryo tissue necrosis, enlarged adenohypophysis, eyelids open at birth, fusion of vertebral arches, heterochrony, homeostasis/metabolism phenotype, improved glucose tolerance, increased bone mineral content, increased circulating glucose level, increased enterocyte apoptosis, increased lean body mass, increased susceptibility to induced colitis, lethality, complete penetrance, neonatal lethality, complete penetrance, no abnormal phenotype detected, preweaning lethality, complete penetrance, retroesophageal right subclavian artery, symmetric azygos veins